Replies to post #270784 on The Golden Lounge

[Theo]

For the second time in the past 4-6 weeks...

Playing the Novartis (anticipated) commitment announcement due most anytime

[Theo]

Not impressed with Roth Capital as a general rule, but, if accurate then this post (#msg-130702786) does foment an intriguing possibility of "boing-ability" re: the part where it says-

"Conatus price target raised to $12 from $4 at Roth Capital
...following discussions with management, 2016 results, assessment of the competitive cirrhosis space, and clarity from the Novartis (NVS) deal."

They (Roth) got "clarity?? hmmmmmmmmmmmmmmmm